Donald R. Britton
Abbott (United States)(US)Abbott Fund(US)
Publications by Year
Research Areas
Neurotransmitter Receptor Influence on Behavior, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Stress Responses and Cortisol, Neuroendocrine regulation and behavior
Most-Cited Works
- → Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty(1982)539 cited
- → A sensitive open field measure of anxiolytic drug activity(1981)245 cited
- → A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets(1992)156 cited
- → Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.(1993)111 cited
- → Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF(1986)99 cited
- → Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration(1991)98 cited
- → A68930: a potent agonist selective for the dopamine D1 receptor(1991)88 cited
- → Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor(1991)63 cited
- → ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.(1996)63 cited
- → (5aR,11bS)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintain behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431)(1995)63 cited